Ok we're having a good day... another of our names is flying - that's 3 of them @ 15%+. Again this is not NEW news to blog readers and this stock was beaten to a pulp in this panic - I actually added a touch first thing this morning to take A-Power Energy Generation (APWR) to a 3.1% stake. This is a good company WITHOUT the wind business, but with the birth of this new line, it's going to be a lot more than good in my opinion. [Jun 27: New Position in A-Power Energy Generation Systems to Create Alternative Energy Mini Basket]A-Power Energy Generation Systems, Ltd. (NASDAQ:APWR - News) ("A-Power"), announced today that it has completed the construction of the first phase of its wind turbine production facility ...

Provectus Pharmaceuticals Inc. (PVCT.OB) is a Tennessee-based development stage pharmaceutical company that specializes in oncology and dermatology therapies. Complementing the company’s lineup of proprietary drugs, Provectus has developed a number of intellectual properties and technologies in the areas of imaging, medical devices, and biotechnology.

In the biotechnology area, the company has developed groundbreaking technology to augment vaccine production and detect viruses. Another area that Provectus is focusing on is the dermatology space. The company is currently conducting Phase 2 clinical trials of their proprietary drug PH-10, to be used as a topical treatment for psoriasis and atopic dermatitis.

Provectus Pharma’s main focus however is in the treatment of cancer. The company is developing advanced therapies to target and destroy the deadliest cancers - melanoma, liver cancer, and breast cancer - while eliminating side effects. Clinical trials for treatment of metastatic melanoma and recurrent breast carcinoma with the company’s PV-10 drug are

...